153 related articles for article (PubMed ID: 34628236)
1. Optimization of bifunctional piperidinamide derivatives as σ
Xiong J; Zhuang T; Ma Y; Xu J; Ye J; Ma R; Zhang S; Liu X; Liu BF; Hao C; Zhang G; Chen Y
Eur J Med Chem; 2021 Dec; 226():113879. PubMed ID: 34628236
[TBL] [Abstract][Full Text] [Related]
2. Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain.
Xiong J; Jin J; Gao L; Hao C; Liu X; Liu BF; Chen Y; Zhang G
Eur J Med Chem; 2020 Apr; 191():112144. PubMed ID: 32087465
[TBL] [Abstract][Full Text] [Related]
3. Benzylaminofentanyl derivates: Discovery of bifunctional μ opioid and σ
Zhuang T; Xiong J; Ren X; Liang L; Qi Z; Zhang S; Du W; Chen Y; Liu X; Zhang G
Eur J Med Chem; 2022 Nov; 241():114649. PubMed ID: 35961067
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain.
Lan Y; Chen Y; Cao X; Zhang J; Wang J; Xu X; Qiu Y; Zhang T; Liu X; Liu BF; Zhang G
J Med Chem; 2014 Dec; 57(24):10404-23. PubMed ID: 25420090
[TBL] [Abstract][Full Text] [Related]
5. Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ
García M; Virgili M; Alonso M; Alegret C; Farran J; Fernández B; Bordas M; Pascual R; Burgueño J; Vidal-Torres A; Fernández de Henestrosa AR; Ayet E; Merlos M; Vela JM; Plata-Salamán CR; Almansa C
J Med Chem; 2020 Dec; 63(24):15508-15526. PubMed ID: 33064947
[TBL] [Abstract][Full Text] [Related]
6. Bifunctional μ opioid and σ
Zhuang T; Xiong J; Hao S; Du W; Liu Z; Liu B; Zhang G; Chen Y
Eur J Med Chem; 2021 Nov; 223():113658. PubMed ID: 34175542
[TBL] [Abstract][Full Text] [Related]
7. Thiophenpiperazine amide derivatives as new dual MOR and σ
Fan Z; Xiao Y; Shi Y; Hao C; Chen Y; Zhang G; Zhuang T; Cao X
Biochem Biophys Res Commun; 2024 Feb; 697():149547. PubMed ID: 38245926
[TBL] [Abstract][Full Text] [Related]
8. 4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ
García M; Virgili M; Alonso M; Alegret C; Fernández B; Port A; Pascual R; Monroy X; Vidal-Torres A; Serafini MT; Vela JM; Almansa C
J Med Chem; 2020 Mar; 63(5):2434-2454. PubMed ID: 31743642
[TBL] [Abstract][Full Text] [Related]
9. Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ
García M; Llorente V; Garriga L; Christmann U; Rodríguez-Escrich S; Virgili M; Fernández B; Bordas M; Ayet E; Burgueño J; Pujol M; Dordal A; Portillo-Salido E; Gris G; Vela JM; Almansa C
J Med Chem; 2021 Jul; 64(14):10139-10154. PubMed ID: 34236190
[TBL] [Abstract][Full Text] [Related]
10. Exploiting the Power of Stereochemistry in Drug Action: 3-[(2
Turnaturi R; Pasquinucci L; Chiechio S; Grasso M; Marrazzo A; Amata E; Dichiara M; Prezzavento O; Parenti C
ACS Chem Neurosci; 2020 Apr; 11(7):999-1005. PubMed ID: 32186844
[TBL] [Abstract][Full Text] [Related]
11. Novel
Turnaturi R; Chiechio S; Pasquinucci L; Spoto S; Costanzo G; Dichiara M; Piana S; Grasso M; Amata E; Marrazzo A; Parenti C
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014375
[TBL] [Abstract][Full Text] [Related]
12. A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.
Lei W; Vekariya RH; Ananthan S; Streicher JM
J Pain; 2020; 21(1-2):146-160. PubMed ID: 31201990
[TBL] [Abstract][Full Text] [Related]
13. The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception.
Sánchez-Blázquez P; Cortés-Montero E; Rodríguez-Muñoz M; Merlos M; Garzón-Niño J
Mol Brain; 2020 Nov; 13(1):150. PubMed ID: 33176836
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effects of a novel pH-dependent μ-opioid receptor agonist in models of neuropathic and abdominal pain.
Rodriguez-Gaztelumendi A; Spahn V; Labuz D; Machelska H; Stein C
Pain; 2018 Nov; 159(11):2277-2284. PubMed ID: 29994988
[TBL] [Abstract][Full Text] [Related]
15. Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.
Deekonda S; Cole J; Sunna S; Rankin D; Largent-Milnes TM; Davis P; BassiriRad NM; Lai J; Vanderah TW; Porecca F; Hruby VJ
Bioorg Med Chem Lett; 2016 Jan; 26(1):222-7. PubMed ID: 26611918
[TBL] [Abstract][Full Text] [Related]
16. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
17. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
Largent-Milnes TM; Guo W; Wang HY; Burns LH; Vanderah TW
J Pain; 2008 Aug; 9(8):700-13. PubMed ID: 18468954
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel 6,7-dihydro-5H-cyclopenta[d]pyrimidine and 5,6,7,8-tetrahydroquinazoline derivatives as sigma-1 (σ1) receptor antagonists for the treatment of pain.
Lan Y; Songyang Y; Zhang L; Peng Y; Song J
Bioorg Med Chem Lett; 2016 Apr; 26(8):2051-6. PubMed ID: 26947609
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain.
Merlos M; Burgueño J; Portillo-Salido E; Plata-Salamán CR; Vela JM
Adv Exp Med Biol; 2017; 964():85-107. PubMed ID: 28315267
[TBL] [Abstract][Full Text] [Related]
20. 2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance.
Fu K; Xu W; Yang R; Zhao H; Xu H; Wei Y; Liu H; Qiu Y; Chen D; Guo D; Xiong B
Eur J Med Chem; 2023 Mar; 249():115178. PubMed ID: 36753922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
